Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem(Northwestern University), Robert J. Lewandowski(Society of Interventional Radiology), Ryan Hickey(New York University), Al B. Benson(Northwestern University), Joseph R. Kallini(Northwestern University), Mary F. Mulcahy(Northwestern University), S. Mouli(Northwestern University), Alfred Rademaker(Northwestern University), Kush Desai(Northwestern University), Michaël Abécassis(University of Arizona), Vahid Yaghmai(Virginia Commonwealth University Medical Center), Frank H. Miller(Northwestern University), Laura Kulik(Northwestern University), Bartley Thornburg(Northwestern Memorial Hospital), Andrew C. Gordon(Northwestern University), Daniel Ganger(Northwestern University), Talia Baker(University of Utah), Kent T. Sato(Society of Interventional Radiology), Ahmed Gabr(Northwestern University)
Cited by 686
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k